Envoy Medical Reports Definitive Agreement and Equity Sales
Ticker: COCHW · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1840877
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, financial-reporting
TL;DR
Envoy Medical inked a deal, sold some stock, and filed financials on March 6th.
AI Summary
Envoy Medical, Inc. entered into a material definitive agreement on March 6, 2025, related to the creation of a direct financial obligation. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. This filing follows the company's previous name change from Anzu Special Acquisition Corp I on January 15, 2021.
Why It Matters
This filing indicates significant financial activity for Envoy Medical, including new obligations and equity transactions, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and unregistered sales of equity, which can introduce financial obligations and dilution risks.
Key Players & Entities
- Envoy Medical, Inc. (company) — Registrant
- Anzu Special Acquisition Corp I (company) — Former company name
- March 6, 2025 (date) — Date of earliest event reported
- January 15, 2021 (date) — Date of name change
FAQ
What type of material definitive agreement did Envoy Medical, Inc. enter into?
The filing indicates the entry into a material definitive agreement related to the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 6, 2025.
What was Envoy Medical, Inc.'s former company name?
Envoy Medical, Inc.'s former company name was Anzu Special Acquisition Corp I.
On what date did the company change its name from Anzu Special Acquisition Corp I?
The company changed its name on January 15, 2021.
What other types of information are reported in this 8-K filing besides the material definitive agreement?
The filing also reports on unregistered sales of equity securities and includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding Envoy Medical, Inc. (COCHW).